SCHEMBL815437

SCHEMBL815437

CCC=CCCCCCCCC(=O)OC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.65
CYP3A4 P08684 2/20 0.65
ALOX15 P16050 2/20 0.65
HSD17B10 Q99714 2/20 0.65
TDP1 Q9NUW8 2/20 0.65
TSHR P16473 2/20 0.65
EPHX2 P34913 1/20 0.64
LMNA P02545 2/20 0.61
F7 P08709 2/20 0.58
F3 P13726 2/20 0.58
MAPT P10636 2/20 0.58
CYP19A1 P11511 2/20 0.58
NR1I2 O75469 2/20 0.58
PTGS2 P35354 2/20 0.58
OXER1 Q8TDS5 2/20 0.58
KDM4E B2RXH2 1/20 0.58
MEN1 O00255 1/20 0.58
FFAR1 O14842 1/20 0.58
PLA2G1B P04054 1/20 0.58
HPGD P15428 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17365707 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL31512561 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL503881 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL23700182 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL2533002 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL23700183 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL14672912 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL14672913 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL816605 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL31512518 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4ALOX15HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 696 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400951-A1 COMPOSTION AND ITS USE IN CLEANING APPLICATIONS INTELLIGENT FLUIDS GMBH (DE) 2024-12-05 US claimed
EP-4408962-A1 COMPOSITION AND ITS USE IN CLEANING APPLICATIONS intelligent fluids GmbH (DE) 2024-08-07 EP claimed
CN-118043441-A Compositions and their use in cleaning applications 智能流体有限公司 2024-05-14 CN claimed
US-11926790-B2 Compositions and methods using subterranean treatment fluids comprising water-soluble polymers HALLIBURTON ENERGY SERVICES, INC. (US) 2024-03-12 US claimed
US-11866645-B1 Methods for hydraulic fracturing and flowback fluid compositions suitable for such SAUDI ARABIAN OIL COMPANY (SA) 2024-01-09 US claimed
US-11643591-B2 Polyamine polyethers as nonemulsifier components HALLIBURTON ENERGY SERVICES, INC. (US) 2023-05-09 US claimed
US-20230134594-A1 UNSATURATED FLUXING AGENTS FOR BITUMINOUS BINDERS VINCI CONSTRUCTION (FR) 2023-05-04 US claimed
WO-2023052548-A1 COMPOSITION AND ITS USE IN CLEANING APPLICATIONS INTELLIGENT FLUIDS GMBH (DE) 2023-04-06 WO claimed
US-20230060530-A1 COMPOSITIONS AND METHODS USING SUBTERRANEAN TREATMENT FLUIDS COMPRISING WATER-SOLUBLE POLYMERS HALLIBURTON ENERGY SERVICES, INC. 2023-03-02 US claimed
EP-2970813-B1 MALEINIZED ESTER DERIVATIVES WILMAR TRADING PTE LTD (SG) 2022-12-14 EP claimed
WO-2014164597-A1 MALEINIZED ESTER DERIVATIVES ELEVANCE RENEWABLE SCIENCES, INC. (US) 2014-10-09 WO claimed
US-8846587-B2 Functionalized monomers and polymers ELEVANCE RENEWABLE SCIENCES, INC. (US) 2014-09-30 US claimed
US-20140274832-A1 MALEINIZED ESTER DERIVATIVES ELEVANCE RENEWABLE SCIENCES, INC. (US) 2014-09-18 US claimed
WO-2014058867-A1 METHODS OF REFINING AND PRODUCING DIBASIC ESTERS AND ACIDS FROM NATURAL OIL FEEDSTOCKS ELEVANCE RENEWABLE SCIENCES, INC. (US) 2014-04-17 WO claimed
CN-103562361-A Functionalized monomers ELEVANCE RENEWABLE SCIENCES 2014-02-05 CN claimed
EP-2688988-A2 FUNCTIONALIZED MONOMERS Elevance Renewable Sciences, Inc. (US) 2014-01-29 EP claimed
WO-2013163071-A1 UNSATURATED FATTY ALCOHOL COMPOSITIONS AND DERIVATIVES FROM NATURAL OIL METATHESIS ELEVANCE RENEWABLE SCIENCES, INC. (US) 2013-10-31 WO claimed
US-20130281688-A1 UNSATURATED FATTY ALCOHOL COMPOSITIONS AND DERIVATIVES FROM NATURAL OIL METATHESIS ELEVANCE RENEWABLE SCIENCES, INC (US) 2013-10-24 US claimed
US-20120264662-A1 FUNCTIONALIZED MONOMERS ELEVANCE RENEWABLE SCIENCES 2012-10-18 US claimed
WO-2012129482-A2 FUNCTIONALIZED MONOMERS ELEVANCE RENEWABLE SCIENCES (US) 2012-09-27 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264662-A1 FUNCTIONALIZED MONOMERS MEP1A, MLEC, ADH1A ALDH1A1 83/4885CYP3A4 705/4885ALOX15 1075/4885
US-20130281688-A1 UNSATURATED FATTY ALCOHOL COMPOSITIONS AND DERIVATIVES FROM NATURAL OIL METATHESIS FASN, ADH1A, ADH5 ALDH1A1 47/4885CYP3A4 824/4885ALOX15 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.